Navigation Links


Induction in Medical News

New Report Just Published: World Multiple Myeloma Therapeutics Market Report

... is also analyzed by the Lines of Treatment -- induction Therapy for SCT Candidates, induction Therapy for Non-SCT Candidates, and Therapy for ... II-28 Initial Treatment Regimen II-28 induction Therapy for SCT Candidates II-28 ...

U-M study finds voice box can be preserved, even with the largest cancers

... Study participants were given one round of induction chemotherapy, an initial dose designed to see if ... Those whose tumors did not respond to the induction chemotherapy were referred for surgery. ... two studies. Eighty-one percent responded to the induction chemotherapy and many saw their tumors shrink ...

Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights

... studies in animals that demonstrated stable induction of interferon-dependent pathways at doses that ... serious adverse events were reported. Biomarker induction indicative of immune activation was seen in a ... 800 mg and 1200 mg dose levels, minimal immune induction and no significant viral load decrease was noted. ...

St. Jude finds more than 100 gene variations linked with response to leukemia treatment

... of leukemic cells that survive after remission induction therapythe initial treatment. This measurement ... less-toxic treatment; and also shows if remission induction therapy will likely fail. The researchers ... and an increased risk of high MRD at the end of induction therapy. "Our finding that IL15 plays such an ...

Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia

... treatment of life-threatening anemia secondary to induction chemotherapy in patients with acute myeloid ... are unable to undergo potentially life-saving induction chemotherapy because of the profound anemia the ... 100% mortality within several months without induction chemotherapy. Biopure Corporation ...

Novel treatments show improvements in survival and response rates for leukemia and lymphoma

... fever, and mucositis. Dexamethasone in induction Can Eliminate One-Third of All Relapses in ... study found that the use of dexamethasone in the induction phase of combination chemotherapy led to a ... dexamethasone, rather than prednisone, as part of induction therapy. Following a pre-phase treatment ...

Novel Treatments Demonstrate Improvements in Overall Survival and Response Rates in Difficult-To-Treat Forms of Leukemia and Lymphoma

... fever, and mucositis. Dexamethasone in induction Can Eliminate One-Third of All Relapses in ... study found that the use of dexamethasone in the induction phase of combination chemotherapy led to a ... dexamethasone, rather than prednisone, as part of induction therapy. Following a pre-phase treatment ...

Multiple Independent Studies Report on Use of Cylex's Immune Cell Function Assay in Postoperative Monitoring of Kidney, Liver, and Heart Transplant Recipients

... viremia. Sunday, June 1, 2008 -- "Effect of induction agent on cellular and humoral responses to renal ... of renal transplant patients to two different induction agents in this study from Johns Hopkins ... Session: Kidney Immunosuppression: induction Therapy I) This study from the ...

Shire Launches Patient Education Forums on Better Managing the Challenges of Ulcerative Colitis

... once-daily LIALDA(TM) (mesalamine) for the induction of remission in patients with active, mild to ... also markets PENTASA(R) (mesalamine) for the induction of remission and treatment of patients with mild ... for LIALDA LIALDA tablets are indicated for the induction of remission in patients with active, mild to ...

BMP Sunstone's Propess(R) Recommended as First Line Treatment By the Chinese Medical Association

... Association as the first line treatment for labor induction in late-stage pregnancy. The Guidelines for Labor induction in Late-Stage Pregnancy was published in the ... the obstetrics field for cervical ripening in the induction of labor. Cytokine PharmaSciences is focused on ...

VELCADE(R) (Bortezomib) for Injection Based Therapy Produced Significant Complete Remission Rates Pre- and Post-Transplantation in IFM Phase III Front-Line Multiple Myeloma Trial

... complete remission rate of 21 percent with this induction therapy significantly improved ... of the trial. "Historically, regimens used as induction therapy prior to stem cell transplantation ... presented by Professor Harousseau: -- As induction therapy prior to SCT, the VcD arm demonstrated a ...

Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma

... ) "This VELCADE based induction regimen achieved a fourfold increase in the ... demonstrated that adding VELCADE to the standard induction therapy prior to stem cell transplantation ... trial were presented by Professor Cavo: -- As induction therapy prior to stem cell transplantation (SCT), ...

AUA releases new guidelines on non-muscle invasive bladder cancer

... tumors, and the use of these agents in single induction courses compared to use as maintenance therapies. ... over chemotherapy for low risk disease. induction courses of either intravesical chemotherapy or ... recurrence but low risk of progression. An induction course of mitomycin C in conjunction with ...

Three Chemo Drugs Better Than Two for Advanced Head/Neck Cancers

... toxicity. With the inclusion of the [three-drug induction chemotherapy] followed by chemoradiotherapy, we ... what he said oncologists want to know is whether induction chemotherapy (as was done in these studies) plus ... than chemoradiotherapy alone. The addition of induction therapy, said Pfister, adds about three months to ...

Induced Labor May Improve Outcome in Risky Pregnancies

... results of our trial are important for both developed countries in which induction of labor in women with hypertensive disease beyond 36 weeks' gestation has ... University Medical Centre Groningen, and colleagues. "Our finding that induction of labor was associated with a reduced risk of severe hypertension or ...

Shire Expands Gastrointestinal Patient Assistance Program for Uninsured or Unemployed Americans

... Lialda Important Safety Information Lialda is approved for the induction of remission in patients with active, mild to moderate ulcerative colitis. ... PENTASA Important Safety Information PENTASA is approved for the induction of remission and for the treatment of mildly to moderately active ...

Vion Pharmaceuticals Reports 2009 First Quarter Results

... its lead anticancer agent Onrigin (laromustine) Injection for remission induction treatment for patients sixty years of age or older with de novo ... The Company has an NDA under review with the FDA for Onrigin for remission induction treatment for patients sixty years of age or older with de novo ...

Tips from the American Journal of Pathology

... Chung MJ, Ullenbruch M, Yu H, Lowe JB, Phan SH: Notch1 signaling in FIZZ1 induction of myofibroblast differentiation. Am J Pathol 2009, 174: 1745-1755 ... injury of the podocyte. [These] findings support a causal role for induction of the matricellular protein SPARC in mediating podocyte loss, thereby ...

Vion Pharmaceuticals Receives a Standard Review from the FDA for Its New Drug Application for Onrigin(TM)

... The NDA presents data for Onrigin(TM) as a single agent for remission induction treatment for patients sixty years of age or older with de novo ... The FDA is reviewing a New Drug Application for Onrigin(TM) for remission induction treatment for patients sixty years of age or older with de novo ...

Vion Pharmaceuticals' New Drug Application for Onrigin(TM)Accepted For Review by the FDA

... 2009. The NDA presents data for Onrigin as a single agent for remission induction treatment for patients sixty years of age or older with de novo ... The FDA is reviewing a New Drug Application for Onrigin for remission induction treatment for patients sixty years of age or older with de novo ...

3-drug chemotherapy combination increases organ preservation in patients with larynx cancer

... combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients ... and hypopharynx cancer in a randomized controlled trial. Patients received induction chemotherapy with either TPF or PF. Those who responded to chemotherapy ...

Late Preterm Birth Poses Developmental Risks

... Caesarean or induction should not be done before 39 weeks unless necessary, study says ... release. She added that elective delivery through Caesarean section or induction should not be performed before 39 weeks unless medically necessary. ...

Late preterm births present serious risks to newborns

... and stresses that elective delivery through cesarean section or induction should not be performed before 39 weeks unless medically necessary. ... to be aware of the risks when considering infertility treatments and induction of labor. ...

Towards improved immunotherapy

... Immunology Society (CIS), describes a new method that facilitates the induction of a specific type of immune suppressive cells, called 'regulatory T ... in Munich, Germany, describe a unique strategy that facilitates the induction of regulatory T cells ex vivo with subsequent expansion to numbers ...

Trailblazing pain pioneer Ronald Melzack to be inducted into Medical Hall of Fame

... "We congratulate this great McGill scholar on his richly deserved induction into the Canadian Medical Hall of Fame." "The selection of this year's ... of Canada's leading citizens will come together to celebrate the formal induction of the incoming laureates on April 29, 2009, in Montreal. ...

Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal

... Phase III, placebo-controlled trials that demonstrated efficacy for the induction of remission in active, mild to moderate UC -- and 213 patients who ... Safety Information for Lialda Lialda tablets are indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis. ...

Cell-Mediated Immunity and Anti-HLA Antibody Tests Provide Insight to Immune Response in Renal Transplant Patients

... enrolled in a protocol of immunosuppression minimization using depletion induction and monotherapy.(1) They have also determined humoral sensitization ... of 200 living donor kidney transplants using alemtuzumab induction and tacrolimus monotherapy: 3 year follow-up. Abstract no. 221 ...

Study finds unique HIV vaccine formula elicits strong immune responses

... have long believed that a final, effective HIV vaccine will require the induction of balanced responses from both arms of human immune system. Our results ... HIV vaccine strategy will offer an alternative approach to focus on the induction of protective antibodies for HIV vaccine development, while maintaining ...

Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients

... of response or intolErance to infliximab. It consists of an open-label induction phase (400 mg of Cimzia(R) sub-cutaneously at Weeks 0, 2 and 4) and a ... was defined as a CDAI score of less than or equal to 150 points. After the induction period, 62.2 percent of patients achieved response and 39.3 percent ...

National Inventors Hall of Fame announces 2008 inductees

... Every year, the National Inventors Hall of Fame honors through induction the individuals whose work has changed society and improved the way we ... The 2008 class will be inducted this year on May 2nd and 3rd at the annual induction ceremonies held in Akron, Ohio. This years group of inventors who ...

Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives

... Safety Information for LIALDA LIALDA tablets are indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis. ... Important Safety Information for PENTASA PENTASA is indicated for the induction of remission and for the treatment of patients with mildly to moderately ...

Sanofi-aventis Announces a Good Third Quarter Performance; Increase in 2007 full-year earnings growth guidance

... Taxotere(R) in association with cisplatin and 5-fluorouracil for the induction (neo-adjuvant) therapy of patients with locally-advanced squamous cell ... approval of Taxotere(R) in the European Union as an induction treatment for locally advanced head and neck cancer. ...

Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells

... Fisher's laboratory, that activates a protein called NOXA that is involved with programmed cell death. This series of chemical reactions results in induction of a cell-killing process involving self-digestion that leads to programmed cell death specifically in melanoma cells. Fisher said that mda-5 is a ...

Researchers identify new method to selectively kill metastatic melanoma cells

... Fisher's laboratory, that activates a protein called NOXA that is involved with programmed cell death. This series of chemical reactions results in induction of a cell-killing process involving self-digestion that leads to programmed cell death specifically in melanoma cells. Fisher said that mda-5 is a ...

FREE INFERTILITY SEMINAR: Fertility Options 101

... July 27 /PRNewswire/ -- During this free monthly seminar, we cover issues related to the diagnosis and treatment of infertility with ovulation induction and insemination, surgery as well as in vitro fertilization including the emotional, scientific and financial aspects. Discussions include ...

Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma

... QPI-1007 was administered immediately after the optic nerve injury. In the current IOP study, QPI-1007 was administered 2 weeks after disease induction when more than 25% of RGCs have already been lost. Whereas RGC loss progressed in the control eyes, loss of RGCs was completely blocked in the ...

Human cells secrete cancer-killing protein, UK study finds

... Par-4 signaling via cell surface GRP78. Thus, the researchers conclude, Par-4 activates a novel pathway involving cell surface GRP78 receptor for induction of apoptosis. In other words, without Par-4, TRAIL lacks the ability to cause "cell suicide." Rangnekar first discovered the Par-4 gene in 1993. ...

Study demonstrates the anti-inflammatory properties of pine bark extract

... production of COX-2, 5-LOX and FLAP enzymes upon pro-inflammatory stimulation. Taking Pycnogenol almost entirely subdued COX-2, 5-LOX and FLAP induction in the immune cells of volunteers. Control studies showed that Pycnogenol did not have an effect on generation of the COX-1 enzyme, thus the ...

Study Demonstrates the Anti-Inflammatory Properties of Pine Bark Extract on Inflammatory Mediators COX-2 and 5-LOX

... production of COX-2, 5-LOX and FLAP enzymes upon pro-inflammatory stimulation. Taking Pycnogenol(R) almost entirely subdued COX-2, 5-LOX and FLAP induction in the immune cells of volunteers. Control studies showed that Pycnogenol(R) did not have an effect on generation of the COX-1 enzyme, thus the ...

Blood vessel bends and branches put the brakes on statins

... please call the BHF press office on 020 7554 0164 or 07764 290 381 (out of office hours) or email newsdesk (at) bhf.org.uk Notes to editors (1) induction of the cytoprotective enzyme heme oxygenase-1 by statins is enhanced in vascular endothelium exposed to laminar shear stress and impaired by ...
Other Contentsfragilefragilefragilefragilefragilefrostbitefrontalfrontalfrontalfrontalfrontalfunnelfunnelfurniturefurniturefurniturefurniturefuruncle
(Date:11/25/2009)...ria don,t have easy lives. In addition to mammalia...natural enemies called bacteriophages, viruses tha... , Still, bacteria and another class of microorg... environments such as deep-sea volcanic vents) man...e a built-in defense system that helps protect the...
(Date:11/25/2009)... a lifetime, the heart pumps some 250 million lite...his, the muscle fibers of the heart have to be ext...olfgang Rottbauer, vice chair of the Department of...hairman: Prof. Dr. H. A. Katus), has discovered a ...he smallest muscular unit, the sarcomere. In coope...
(Date:11/24/2009)... Institute (LRI) today named 12 new grant recipien...cognize innovative work across a broad spectrum of...ivity, novelty, and potential to drive scientific ...he complex disease of systemic lupus. , The 2009...rchers across the nation and include interdiscipli...
Breaking Biology News(10 mins):Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3New genetic cause of cardiac failure discovered 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3 R E P E A T DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58843 1 R E P E A T DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58843 2 R E P E A T DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58843 3Cord Blood America Continues to Reduce Debt 3B Three Notes Retired 5207 1Cord Blood America Continues to Reduce Debt 3B Three Notes Retired 5207 2DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58841 1DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58841 2DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58841 3
(Date:11/27/2009)..., KIBBUTZSHAMIR,Israel,Nov.27/PRNewswire-FirstCal...mir" ),aleadingproviderofinnovativeproductsandtech...itsboardofdirectorshaddeclaredadividenddistributio...S37.62millionbasedontheNovember25,2009representati...atelyNIS2.3basedontheNovember25,2009representative...
(Date:11/27/2009)...ng rates to bring unprecedented medical, economic ... 27 (HealthDay News) -- The number of people with ...e over the next 25 years, a new study predicts. ,...1 million people with the disease, up from 23.7 mi...reating people with diabetes will triple, the stud...
(Date:11/27/2009)... Multi-purpose bilingual color...gned for use by the business community to educate ...f subjects from Safety issues to Dinosuars to ABC,... Saint Louis, MO (PRWEB) November 27, 2009 -...tronics or toys to keep them busy any hour of the ...
(Date:11/26/2009)..., NEWYORK,Nov.27/PRNewswire/--Withcoldandfluseaso...icestocontrolthespreadofinfectionsandavoidillness....ealthy,buttoavoidtransmittingillnessifwe,resick,"s...ntrol),nursingdirectorforinfectioncontrolandoccupa...attan. ,, HospitalforSpecialSurgeryhasoneofthel...
(Date:11/26/2009)... copper sequestering drug tetrathiomolybdate (TM) ...reatment of Wilson disease, a disease caused by an...s. That much is known. Very little, however, is kn...l. , A new study led by Northwestern University ...he three-dimensional structure of TM bound to copp...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
Other TagsHeartsHeartsHeartsEcologyMachineMachineMachineMachineNitricLegalLegalPrematurePrematureOther Tagselevate 2advanced 2advanced 3advanced 4advanced 5advanced 6advanced 7advanced 8advanced 9advanced 10innovative 2innovative 3innovative 4innovative 5innovative 6innovative 7innovative 8innovative 9innovative 10rainforest 2world 2world 3world 4world 5world 6world 7world 8world 9world 10strategic 2